Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System
| The Manila Times
New system expands the Company’s leadership in interventional glaucoma with the first FDA cleared MIGS device for single pass canaloplasty with TruSync™ Plus innovation.